Accuray Company Profile (NASDAQ:ARAY)

Analyst Ratings

Consensus Ratings for Accuray (NASDAQ:ARAY) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $9.75 (81.90% upside)

Analysts' Ratings History for Accuray (NASDAQ:ARAY)
Show:
DateFirmActionRatingPrice TargetActions
5/22/2016Brean CapitalReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/1/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Royal Bank Of CanadaLower Price TargetSector Perform$8.00 -> $7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Citigroup Inc.Initiated CoverageSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Dougherty & CoLower Price TargetBuy$10.75 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2015SidotiInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015Northland SecuritiesInitiated CoverageOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014SunTrust Banks Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Accuray (NASDAQ:ARAY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/17/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2016Q316($0.06)$0.01$102.79 million$105.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q216($0.08)($0.08)$101.15 million$108.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q116($0.14)($0.12)$88.60 million$89.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/20/2015Q415($0.04)($0.07)$102.41 million$101.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q315($0.06)($0.04)$102.72 million$97.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2015Q215($0.08)($0.13)$98.87 million$98.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q115($0.13)($0.28)$88.90 million$82.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/21/2014Q414($0.07)($0.13)$92.23 million$102.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q314($0.16)($0.06)$82.00 million$97.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q214($0.20)($0.07)$80.20 million$93.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q114($0.20)($0.21)$79.67 million$76.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/27/2013Q4 2013($0.20)($0.20)$82.29 million$84.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q3 2013($0.22)($0.37)$77.97 million$70.55 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q2 2013($0.33)($0.30)$74.23 million$77.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q113($0.22)($0.23)$85.41 million$83.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/6/2012Q412($0.12)($0.20)$106.92 million$100.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012($0.14)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011($0.29)($0.38)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/19/2011$0.02($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.04($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011($0.01)$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Accuray (NASDAQ:ARAY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q4 20161($0.08)($0.08)($0.08)
Q1 20171($0.07)($0.07)($0.07)
Q2 20171($0.01)($0.01)($0.01)
Q3 20171$0.04$0.04$0.04
Q4 20171$0.06$0.06$0.06
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Accuray (NASDAQ:ARAY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Accuray (NASDAQ:ARAY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/9/2015Joshua LevineCEOBuy50,000$7.12$356,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Alaleh NouriSVPSell5,164$7.38$38,110.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2014Alaleh NouriSVPSell268$6.62$1,774.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2014Kelly LondyEVPSell2,273$6.62$15,047.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Joshua LevineCEOBuy100,000$6.34$634,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Joshua LevineCEOBuy50,000$8.15$407,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Richard PettingillDirectorBuy9,795$10.33$101,182.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Jack GoldsteinDirectorSell7,000$7.70$53,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Elizabeth DavilaDirectorSell8,000$7.74$61,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Darren J MillikenSVPSell11,002$6.53$71,843.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2013Dennis L WingerDirectorBuy20,000$4.30$86,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2013Joshua LevineCEOBuy100,000$4.38$438,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Accuray (NASDAQ:ARAY)
DateHeadline
07/22/16 10:46 AMTomoTherapy system provides favourable outcomes in low-risk breast cancer patients
07/22/16 10:46 AMTomoTherapy System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
07/22/16 08:09 AMTrade These 5 Biotech Breakouts Now for Big Gains -
07/21/16 08:09 PMU S index of leading economic indicators on rise in June
07/21/16 08:09 PMAccuray's TomoTherapy offers favorable outcomes in breast cancer treatment: study
07/21/16 09:53 AMAccuray : TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
07/21/16 09:53 AMTomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
07/20/16 03:44 PMAccuray Incorporated Formed a Bearish Multiple Bottom Chart Pattern, Could Be One of The Worst Performers Going ... - Consumer Eagle
07/20/16 03:44 PMAccuray (NASDAQ:ARAY) Short Interest Decreased By 9.37% - Consumer Eagle
07/19/16 02:33 PMHow Analysts Feel About Accuray Incorporated (NASDAQ:ARAY)? - Consumer Eagle
07/16/16 10:34 AMAccuray (NASDAQ:ARAY) Sellers Increased By 12.05% Their Shorts - Consumer Eagle
07/14/16 06:28 AMAccuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report - [at noodls] - SUNNYVALE, Calif., July 14, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its CyberKnife and TomoTherapy Systems continue to set the standard for overall user satisfaction. ...
07/13/16 10:41 AMAccuray Incorporated (ARAY) is Trading Higher on Unusual Volume for July 11
07/12/16 08:03 PMAccuray Incorporated (ARAY) is Trading Higher on Unusual Volume for July 11 - Equities.com
07/12/16 06:05 PMHow Has Varian Medical Systems Progressed in Radiotherapy? -
07/12/16 07:06 AMAccuray, Inc. breached its 50 day moving average in a Bullish Manner : ARAY-US : July 12, 2016 -
07/12/16 06:29 AMUpdated Analysts Rating Report: Accuray Incorporated (NASDAQ:ARAY) , Sangamo BioSciences, Inc. (NASDAQ:SGMO) - Street Updates
07/10/16 02:31 PMAccuray Incorporated (ARAY) Jumps 5.92% on July 08
07/09/16 10:37 AMAccuray Incorporated (ARAY) Jumps 5.92% on July 08 - Equities.com
07/08/16 02:34 PMAccuray Incorporated versus GenMark Diagnostics, Inc. Head to Head Compare - CML News
07/07/16 03:31 PMAccuray To Report Fiscal 2016 Fourth Quarter And Full Year Results On August 17, 2016 - [at noodls] - SUNNYVALE, Calif., July 7, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2016 on Wednesday, August 17, 2016 after ...
07/06/16 02:35 PMAccuray Inc (NASDAQ:ARAY) Institutional Investors 2016 Q1 Sentiment - Engelwood Daily
07/05/16 07:18 AMTechnical Coverage on Medical Appliances & Equipment Stocks - Edwards Lifesciences, Stryker, Accuray, and ABIOMED - PR Newswire (press release)
07/04/16 02:31 PMAccuray (NASDAQ:ARAY) Shorted Shares Increased 12.05% After Market Selling - Press Telegraph
07/04/16 07:22 AMAre Analysts Bearish Accuray Incorporated (NASDAQ:ARAY) After Last Week? - Engelwood Daily
06/30/16 02:43 PMAccuray Incorporated (NASDAQ:ARAY) Company Rating and Target Watch - Telanagana Press
06/29/16 02:33 PMRecently Issued Stock Ratings For Accuray Incorporated (NASDAQ:ARAY) - Fiscal Standard
06/29/16 10:46 AMShare Update and Earnings Review for Accuray Incorporated (NASDAQ:ARAY) - Press Telegraph
06/28/16 07:49 AMAccuray Receives 510(k) FDA Clearance for the Radixact Image-Guided Radiation Therapy Platform and Integrated Software
06/28/16 07:49 AMAccuray Receives 510(k) Clearance For New Radixact System - Quick Facts
06/28/16 07:49 AMAccuray receives 510(k) clearance for Radixact IGRT platform and software
06/28/16 07:49 AMAccuray's (ARAY) Radixact Treatment Delivery Platform Receives FDA 510(k) Clearance
06/28/16 07:49 AMAccuray receives 510(k) FDA clearance for the Radixact
06/27/16 07:18 AMHow Analysts Feel About Accuray Incorporated (NASDAQ:ARAY)? - Press Telegraph
06/27/16 05:41 AMAccuray Receives 510(k) FDA Clearance for the Radixact™ Image-Guided Radiation Therapy Platform and Integrated Software - [at noodls] - SUNNYVALE, Calif., June 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radixact™ ...
06/24/16 02:32 PMNew Broker Ratings For Accuray Incorporated (NASDAQ:ARAY) - FTSE News
06/24/16 09:00 AMAccuray's (ARAY) TomoTherapy System Uptake on the Rise -
06/22/16 02:32 PMStrong Buy Calls Count For Accuray Incorporated (NASDAQ:ARAY) At 3 - Investor Newswire
06/21/16 02:31 PMAccuray Incorporated (NASDAQ:ARAY) Stock Momentum Hits Extreme Weakness - CML News
06/21/16 05:49 AMFUCAM Treats 1,000 Breast Cancer Patients with the TomoTherapy® System - [at noodls] - SUNNYVALE, Calif., June 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Fundación de Cancer de Mama in México City (FUCAM) has treated 1,000 breast cancer patients ...
06/18/16 07:17 AMAccuray Incorporated (ARAY) is Trading Higher on Unusual Volume for June 16 - Equities.com
06/17/16 02:30 PMTwo Stocks within Traders Limelight: Accuray Incorporated (NASDAQ:ARAY) , Capricor Therapeutics, Inc. (NASDAQ ... - Street Updates
06/17/16 07:15 AMAccuray Wins 7 TomoTherapy Orders from NHS, Stock Up -
06/16/16 02:32 PMSummary of Price Movements: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) , Accuray Incorporated (NASDAQ:ARAY) - Street Updates
06/16/16 02:32 PMEye Catching Stock for investors: Accuray Incorporated (NASDAQ:ARAY) - News Oracle
06/16/16 02:32 PMEarnings Analysis to Watch: Accuray Incorporated (NASDAQ:ARAY), Basic Energy Services, Inc. (NYSE:BAS) - Beacon Chronicle
06/16/16 07:39 AMUnited Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems - [at noodls] - SUNNYVALE, Calif., June 16, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has a signed deal with NHS Supply Chain for seven TomoTherapy® Systems in a new partnership designed to provide clinicians ...
06/16/16 05:31 AM6:31 am Accuray signs deal w/ NHS Supply Chain for seven TomoTherapy Systems in a new partnership; deal entered into backlog during its Q4 -
06/15/16 07:21 AMAccuray Incorporated (ARAY) is Trading Lower on Unusual Volume for June 13 - Equities.com
06/14/16 07:33 AMTrading updates about two Stocks: Intrexon Corporation (NYSE:XON) , Accuray Incorporated (NASDAQ:ARAY) - Street Updates

Social

About Accuray

Accuray logoAccuray Incorporated is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. Its suite of products includes the CyberKnife Systems and the TomoTherapy Systems. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy and adaptive radiation therapy. Its principal radiosurgery products, the CyberKnife Systems are robotic full-body radiosurgery system designed to treat tumors anywhere in the body non-invasively, which include the CyberKnife M6 Series with configuration options of fixed collimators plus iris variable aperture collimator, fixed collimators plus the InCise MLC and fixed collimators plus iris variable aperture collimator and the InCise MLC. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ARAY
  • CUSIP: 00439710
Key Metrics:
  • Previous Close: $5.33
  • 50 Day Moving Average: $5.22
  • 200 Day Moving Average: $5.46
  • P/E Ratio: N/A
  • P/E Growth: 0.08
  • Market Cap: $433.75M
  • Beta: 1.71
  • Current Year EPS Consensus Estimate: $-0.26 EPS
  • Next Year EPS Consensus Estimate: $0.01 EPS
Additional Links:
Accuray (NASDAQ:ARAY) Chart for Saturday, July, 23, 2016